Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shakira Jeanene Grant"'
Autor:
Samuel M. Rubinstein, Eben I. Lichtman, Shakira Jeanene Grant, Christopher E. Jensen, Hyman B. Muss, Nicholas J. Mangieri, Sanah N. Vohra, Allison M. Deal, Lee Jamison, William A. Wood, Sascha A. Tuchman, Kirsten A. Nyrop
Publikováno v:
J Geriatr Oncol
OBJECTIVES: Findings from a brief geriatric assessment (GA) in a cohort of adults with multiple myeloma (MM) are presented, with particular attention to the utility of the GA in identifying important deficits in adults judged to have a normal Karnofs
Autor:
Gabriell Erisnor, Jiona A Mills, Mykela Moore, Lauren C. Bates-Fraser, Paul Mihas, Shakira Jeanene Grant
Publikováno v:
Journal of Clinical Oncology. 40:177-177
177 Background: Older Black adults are disproportionately burdened by multiple myeloma (MM) yet continue to face significant challenges in accessing high-quality cancer care, including opportunities to engage in research. Knowledge of experiments suc
Autor:
Tanya M. Wildes, Eben I. Lichtman, Sascha A. Tuchman, Shakira Jeanene Grant, Hyman B. Muss, Kirsten A. Nyrop, Samuel M. Rubinstein, Allison M. Deal, Hillary M. Heiling
Publikováno v:
Blood. 138:4130-4130
Introduction Physically frail older adults with hematological malignancies experience greater treatment-related toxicity, higher rates of treatment non-completion, increased utilization of health care services, and shorter overall survival than young
Autor:
Hyman B. Muss, Sascha A. Tuchman, Kirsten A. Nyrop, Christopher E. Jensen, Sanah N. Vohra, Shakira Jeanene Grant, Allison M. Deal, Eben I. Lichtman, Samuel M. Rubinstein
Publikováno v:
Journal of Clinical Oncology. 39:e20004-e20004
e20004 Background: Multiple myeloma (MM) and immunoglobulin light chain (AL) amyloidosis are clonal plasma cell disorders (PCDs) of aging, with median ages at diagnosis of 69 and 76 years, respectively. The care of adults with these disorders is ofte
Autor:
Shakira Jeanene Grant, Eben I. Lichtman, Samuel M. Rubinstein, Matthew Jansen, Marjory Charlot, Sascha A. Tuchman
Publikováno v:
Journal of Clinical Oncology. 39:e18540-e18540
e18540 Background: Multiple myeloma (MM) is a disease of aging, associated with one of the greatest black-white disparities in incidence and mortality among all US cancer types. Clinical trials provide the critical evidence-base to inform clinical ma
Publikováno v:
The Journal of Community and Supportive Oncology. 12:415-417
Superior vena cava (SVC) syndrome refers to a constellation of symptoms produced by the obstruction of blood flow through the SVC, resulting in symptoms of dyspnea, facial and upper-extremity edema, cough, chest pain, and dysphagia.1 Malignancies rep
Publikováno v:
Blood. 124:3976-3976
INTRODUCTION High dose chemotherapy (HDC) followed by Autologous stem cell transplant (ASCT) has been shown to provide curative benefit in patients with relapsed lymphoma and multiple myeloma, often times requiring hematopoietic support until marrow
Publikováno v:
Blood. 122:2140-2140
Introduction High dose chemotherapy (HDC) followed by autologous stem cell transplant (ASCT) is considered the standard of care for patients with high-risk or relapsed lymphoma and multiple myeloma (MM). With most patients requiring both red cell tra